Roche

We are pleased to announce today the completion of the acquisition of LumiraDx’s Point of Care technology, enabling us to further accelerate innovation in near-patient care. It will also help to expand patient access to timely diagnostics results in community-based care, especially in low and middle-income countries.

In a world where #hepatitis testing and treatment have been made more accessible, what’s stopping people from getting tested? Societal attitudes and taboos not only discourage individuals from seeking testing, but also perpetuates a harmful culture of silence and blame surrounding the disease. Many people are reluctant to get screened for the fear of being labeled as someone “who deserves it”. The reality is anybody can get hepatitis, but nobody deserves it. In a social experiment we conducted, four people bravely shared their diagnosis. However, millions continue to live in silence. We believe everyone deserves to get tested. By shining a light on hepatitis we can move closer to achieving the World Health Organization 2030 hepatitis elimination goals. Learn more: http://spkl.io/60404C4q0 #WorldHepatitisDay

🚀 We are driving innovation to create new solutions for those living with #Alzheimer's disease. Our unwavering commitment to advancing diagnostic capabilities and pioneering therapeutic strategies shows our dedication to every aspect of the patient journey in #Alzheimer’s disease. Discover all scientific advancements from diagnostics to therapeutics in the link below, join the conversation, and learn more about Roche’s bold vision to improve the lives of people living with Alzheimer’s disease. 🧠🔬 👉 http://spkl.io/60494Cvfl

🌟 Meet Ömer Faruk Öz: Engineering a Sustainable Future at Roche 🌟 From the chemical industry to healthcare innovation, Ömer leverages his skills to drive impactful, sustainable solutions at Roche, contributing significantly to our 2050 climate goals. 🚀 Ready to be inspired? Learn more about our mission and explore opportunities to join us!  » go.roche.com/internshipli  #Roche #Sustainability #HealthcareInnovation #CareerJourney #IP2TIS

Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised. For more details on our performance, click here ➡️ http://spkl.io/60424CQde

#DYK as of 2022, 354 million people globally were living with chronic Hepatitis B or C virus infection. Of those living with viral hepatitis over 80% had not been treated. Recently, John Ward, Director of the Coalition for Global Hepatitis Elimination, spoke about why #hepatitis is often referred to as the “silent dragon”, and the importance of testing, diagnosis, and early treatment in preventing many Hepatitis-related deaths worldwide that could have been avoided. To find out more, watch the full panel discussion: http://spkl.io/60444CSRr

Each person with cancer is unique, so different types of treatment administration, where available, may help to meet different patients’ needs and lifestyles. 👇 Healthcare professionals can share our discussion guide with their patients to enhance conversations about cancer care. Click here to learn more and download our discussion guide: http://spkl.io/60414CuNv

🚀 At Roche, we're revolutionizing healthcare across multiple domains. Whether you're passionate about driving innovative software solutions, uncovering groundbreaking medical insights with AI and data analytics, or ensuring the seamless functioning of critical IT systems, there's a place for you here. Are you interested in shaping the future of medicine and making a real impact? 🌟 Learn more here: https://lnkd.in/exdtBTMJ

We wholeheartedly support the plan to reduce regulatory timelines for new medicines, as proposed in the European Commission’s #EUPharmaLegislation. For patients waiting for the opportunity of new innovative therapies to address their unmet needs, time is of the essence. Yet more can be done to ensure the European health ecosystem delivers for patients in a time sensitive way. See more ⬇️

Fostering a truly inclusive society hinges on freedom for everyone, including individuals living with rare diseases. Every person, regardless of their health challenges, deserves the opportunity to live an independent, dignified life with access to the resources they need. 🌐 In the latest episode of the #SMAMyWay podcast, we explore how we can create tangible change for those living with rare diseases like Spinal Muscular Atrophy (#SMA). 🤝 Tune in, engage, and be part of the movement advocating for a more inclusive world. http://spkl.io/604947hY5